Enfusion, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Platform subscriptions
Managed services
Other
Total revenues
COST OF REVENUES:
Platform subscriptions
Managed services
Other
Total cost of revenues
Gross profit
OPERATING EXPENSES:
General and administrative
Sales and marketing
Technology and development
Total operating expenses
Income (loss) from operations
NON-OPERATING INCOME (EXPENSE):
Interest expense
Payment to related party
Interest income, net
Other expense, net
Total non-operating income (expense)

Income (loss) before income taxes
Income taxes
Net income (loss)
Net income (loss) attributable to non-controlling interests
Net income (loss) attributable to Enfusion, Inc.
Net income (loss) per Class A common shares attributable to Enfusion, Inc.:
Basic
Diluted
Weighted-average number of Class A common shares outstanding:
Basic
Diluted

Comments